Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Forest Labs surprises with strong Celexa sales. (Life Sciences).(Brief Article)(Statistical Data Included)
- FOREST LABORATORIES Inc. surprised on the upside for fiscal second quarter 2003 earnings last week, sent shares of the specialty pharmaceuticals company up $7.84, to $89.85. Forest Labs projects earnings per share EPS to be above the consensus estimate of 57 cents per share by at...
- Research articles 2002-10-07
- Suit vs. Forest Labs Names Execs Linked to Alleged Lies About Lexapro, Celexa
- Employees of Forest Labs and that company's rivals should read the U.S. government's complaint against the company, which alleges off-label promotion of Lexapro and Celexa for use in children. The complaint names executives, indicates who knew what and when, and goes into the details of many individual sales reps' actions....
- Blog posts 2009-02-26
Additional Resources
- Forest Labs' Lexapro Flap Over JAMA Article Will Likely Be Examined by the Feds
- An editor of the Journal of the American Medical Association called a university professor "a nobody and a nothing" after he pointed out, correctly, that a JAMA author had failed to disclose a financial relationship with Forest Labs in an article about Lexapro, according to the WSJ. ...
- Blog posts 2009-03-16
- IVAX Not In Negotiations Regarding A Lexapro Settlement
- MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX), in response to rumors, announced that it is not currently in discussions with Forest Laboratories regarding a settlement in the patent case over escitalopram oxalate, the generic equivalent of LexaproR. The trial between IVAX and Forest is currently scheduled to begin on December...
- Research articles 2005-10-05
- Forest's Lexapro Ghostwriting Budget Was $100K; Emory on the Payroll
- Forest Labs budgeted $100,000 for ghostwriting articles about its antidepressant Lexapro. The news came in a copy of Forest's 2004 Lexapro marketing plan, unveiled by the Senate’s Special Committee on Aging. by Jim Edwards
- Blog posts 2009-09-03
- Caraco Pharmaceutical Laboratories, Ltd. Enters Into Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro® ANDA Patent Litigation
- DETROIT, July 10 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the settlement of the legal proceedings related to LexaproR escitalopram oxalate tablets, it entered into an Asset Purchase Agreement with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's...
- Research articles 2009-07-10
- Forest Laboratories Inc. F1Q10 (Qtr End 06/30/09) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions. And our first question comes from Tim Chiang with FTN Equity Capital. Tim Chiang - FTN Equity Capital I had a question about some of the guidance numbers that you provided last quarters and sort of given the strong uptake of Savella, why you're...
- Earnings calls 2009-07-21
- Forest Labs Q1: $170 Million Fee for DOJ; Its Numbers Are Written in "Invisible Ink"
- Forest Labs is holding a $170 million contingency fee in case it needs to settle allegations by the Department of Justice that it bribed doctors --- with such things as $1,000 gift certificates to Alain Ducasse -- into prescribing Lexapro and Celexa for children even though it was not approved...
- Blog posts 2009-04-23
- Forest Laboratories F3Q07 (Qtr End 12/31/06) Earnings Call Transcript
- Question-and-Answer SessionOperator At this time, I would like to remind everyone, in order to ask a question, please press *, then the number 1 on your telephone keypad. We'll pause for just a moment to compile the Q-and-A roster. The first question comes from Mark Goodman...
- Earnings calls 2007-01-16
- BNET Focus on Antidepressants: Part 1, Sales and Strategy
- Ever since Eli Lilly launched Prozac in the U.S. in 1987, Americans have had a love affair with anti-depressants. Prozac isn't just a pill. It was the cultural touchstone of 1990s -- as a lifesaver, punchline and punching bag. When Prozac went off-patent in 2001, something interesting...
- Blog posts 2008-09-30
- Forest Laboratories Inc. F3Q08 (Qtr End 12/31/07) Earnings Call Transcript
- Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Rich Silver of Lehman Brothers. Rich Silver Lexapro and market share expectations in the past, I think you have said that you had hoped to gain modest market share overtime. Now that there is no longer...
- Earnings calls 2008-01-15
- BNET Focus on Antidepressants: Part 3, the Future
- The future for branded antidepressants as a business looks grim. Here's the current patent expiration schedule for the four biggest sellers: GlaxoSmithKline's Paxil CR expires in 2008 Wyeth's Effexor XR expires in 2011 Forest Labs' Lexapro expires in 2012 Eli Lilly's Cymbalta expires in...
- Blog posts 2008-10-02
- Forest Laboratories Inc., F3Q09 (Qtr End 12/31/08) Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions. The first question comes from the line of Gregory Gilbert with Bank of America-Merrill Lynch. Gregory Gilbert - Bank of America-Merrill Lynch First for Frankie, discuss any changes in trade inventory levels for your key products and also for clarification on that $70...
- Earnings calls 2009-01-20
- JAMA Demands Silence From Those Who Find Conflicts Among Its Authors
- The Journal of the American Medical Association has instituted a bizarre new policy requiring silence from anyone who notices a conflict of interest among its authors. JAMA will require silence about such conflicts until it has "investigated" them, according to the WSJ. The policy is, of course,...
- Blog posts 2009-03-23
- Forest Laboratories, Inc Q1 2009 Earnings Call Transcript
- Question-and-Answer Session Operator Operator Instructions Our first question comes from Ian Sanderson with Cowen. Ian Sanderson – Cowen and Company Hi, good morning, thanks for taking the question. First on the Department of Justice Settlement Provision, why put a reserve in place at this time, given the,...
- Earnings calls 2009-04-21
- Forest Laboratories: Finding Ways to Bring Drugs to Market — Fast
- Pfizer may be big, but Forest Laboratories is nimble. The smaller company competes by ushering drugs through FDA red tape in record time. Giant: Pfizer Shadow Success: Forest Laboratories, Inc. Pfizer market cap: $96.56 billion;...
- Articles 2009-06-10
- Forest Lab's Hard Sell of Anti-Depressant Raises Questions
- Derek Lowe submits: Forest Labs FRX has done very, very well with Lexapro escitalopram over the years. They're a comparatively small company, and their collaboration with Lundbeck (HLUKY.PK) also a comparatively small company in the antidepressant field has been the biggest event in their history. Lexapro...
- External links 2009-09-02
- Justice eyes marketing at J&J, Forest
- It looks as if yet another U.S. drug-marketing investigation is about to be settled. As Dow Jones reports, Forest Laboratories has reached a tentative deal with the feds, which would settle civil allegations that it mismarketed antidepressants and a thyroid drug. But the deal wouldn't cover the government's "ongoing investigation...
- News items 2009-11-10
- Aetna Offers Copay-Free Period to Promote Appropriate Use of Generic Antidepressants
- HARTFORD, Conn. -- Aetna (NYSE:AET) today announced the launch of a program that waives copays for six months when members change from brand-name antidepressants Lexapro or Paxil CR to generics citalopram or paroxetine, respectively. The program is not available in all states or under all benefit plans. This class of...
- Research articles 2007-05-21
- Forest Laboratories Inc. (Active Pharmaceutical Ingredient Watch).(Brief Article)
- FOREST Laboratories Inc. reported a 45 percent increase in earnings per share BPS to 48 cents in the first quarter of fiscal 2004. Net sales rose 5 percent to ... FOREST Laboratories Inc. reported a 45 percent increase in earnings per share BPS to...
- Research articles 2003-07-21
- << Previous
- page 1 of 1
- Next >>
Presented by American Express